Tandem Diabetes Care, Inc. (TNDM)

$18.16-0.51 (-2.73%) Set alert

Data as of Nov 3, 11:22 AM ETPrices may be delayedHow our data works

SMA

Res / Sup are automatic swing levels for educational reference only — not signals or advice.

Prices may be delayed. For informational purposes only — not investment advice.

TNDM key stats

Market cap
$1.33B
P/E (TTM)
—
52-week range
$12.26 – $29.65
Volume
403.84K
Prev close
$18.67
Day range
$18.06 – $18.67
EPS (TTM)
$-0.91
Industry
Surgical & Medical Instruments & Apparatus
41

TNDM GlowScore: Quiet

A 0–100 read on today's activity from volume, momentum and intraday range. Not a buy or sell signal.

Track GlowScore free

About Tandem Diabetes Care, Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.

What's moving TNDM today

Updated November 3, 2026

As of November 3, 2026, Tandem Diabetes Care, Inc. (TNDM) stock fell to $18.16, down 2.73% (-$0.51) versus the previous close. On the day, shares have traded between $18.06 and $18.67. That puts TNDM in the lower third of its 52-week range of $12.26 to $29.65. Tandem Diabetes Care, Inc. operates in the surgical & medical instruments & apparatus space and carries a market capitalization of roughly $1.30 billion, with about 403.8K shares changing hands.

Latest TNDM news

Source: Yahoo Finance RSS · Updated November 3, 2026

Want TNDM headlines, alerts and AI research in one place? Create a free account →

TNDM buzz on Stocktwits

13,901 watchers
Bullish 6tagged in last 30 postsBearish 0
  • $TNDM they have the best algorithm of any insulin pump delivery system and trust is all that matters when your life depends on it. They are building a loyal customer base much like $AAPL who will no doubt have to get into the medical industry sooner or later and microdosing is…

    @fustuyst· Oct 29, 12:04 PM ET

  • $TNDM keep watch if this holds above 18.34

    @StockScanners· Oct 26, 9:32 PM ET

  • $TNDM if the democrats control the coming congress this might climb alot

    @labibaouf· Oct 26, 6:20 PM ET· Bullish

  • @BMWLTWM3 I remember when the 365 got approved by the FDA, I thought we'd hit the moon the following Monday, Nope it went down. Not sure this will ever give us the great return that $DXCM and $TNDM gave us when they popped.

    @Punpire· Oct 26, 4:41 PM ET

  • $TNDM solid entry point for a starter position.

    @Don_Heisenberg· Oct 18, 11:47 AM ET

Source: Stocktwits. User posts are opinions, not verified facts. See what's trending →

TNDM Congress & insider trades

Congress amounts are the disclosed ranges; filings can lag the trade date by up to 45 days.

All TNDM insider filings →

AI research on TNDM

Get an instant AI breakdown of the bull & bear case, key risks, and what analysts are watching.

Live movers & big gappers

See the biggest daily gainers, losers and premarket gappers across the market, updated live.

Track TNDM like a pro — free

Create a free GlowTicker account to build your watchlist, get AI research, live movers and price alerts. Upgrade to PRO anytime for the full firehose.

Live charts AI research Price alerts

Not financial advice. This page is for educational purposes only. Data comes from third-party sources, may be delayed or incomplete, and should not be the basis of any investment decision.

Popular stocks